Literature DB >> 25296321

Computational studies of the effect of the S23D/S24D troponin I mutation on cardiac troponin structural dynamics.

Yuanhua Cheng1, Steffen Lindert2, Peter Kekenes-Huskey2, Vijay S Rao3, R John Solaro4, Paul R Rosevear5, Rommie Amaro6, Andrew D McCulloch7, J Andrew McCammon2, Michael Regnier8.   

Abstract

During β-adrenergic stimulation, cardiac troponin I (cTnI) is phosphorylated by protein kinase A (PKA) at sites S23/S24, located at the N-terminus of cTnI. This phosphorylation has been shown to decrease KCa and pCa50, and weaken the cTnC-cTnI (C-I) interaction. We recently reported that phosphorylation results in an increase in the rate of early, slow phase of relaxation (kREL,slow) and a decrease in its duration (tREL,slow), which speeds up the overall relaxation. However, as the N-terminus of cTnI (residues 1-40) has not been resolved in the whole cardiac troponin (cTn) structure, little is known about the molecular-level behavior within the whole cTn complex upon phosphorylation of the S23/S24 residues of cTnI that results in these changes in function. In this study, we built up the cTn complex structure (including residues cTnC 1-161, cTnI 1-172, and cTnT 236-285) with the N-terminus of cTnI. We performed molecular-dynamics (MD) simulations to elucidate the structural basis of PKA phosphorylation-induced changes in cTn structure and Ca(2+) binding. We found that introducing two phosphomimic mutations into sites S23/S24 had no significant effect on the coordinating residues of Ca(2+) binding site II. However, the overall fluctuation of cTn was increased and the C-I interaction was altered relative to the wild-type model. The most significant changes involved interactions with the N-terminus of cTnI. Interestingly, the phosphomimic mutations led to the formation of intrasubunit interactions between the N-terminus and the inhibitory peptide of cTnI. This may result in altered interactions with cTnC and could explain the increased rate and decreased duration of slow-phase relaxation seen in myofibrils.
Copyright © 2014 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25296321      PMCID: PMC4190606          DOI: 10.1016/j.bpj.2014.08.008

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  44 in total

Review 1.  Regulation of contraction in striated muscle.

Authors:  A M Gordon; E Homsher; M Regnier
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

2.  Cardiac troponin I inhibitory peptide: location of interaction sites on troponin C.

Authors:  M B Abbott; A Dvoretsky; V Gaponenko; P R Rosevear
Journal:  FEBS Lett       Date:  2000-03-10       Impact factor: 4.124

3.  Small-angle neutron scattering with contrast variation reveals spatial relationships between the three subunits in the ternary cardiac troponin complex and the effects of troponin I phosphorylation.

Authors:  William T Heller; Natosha L Finley; Wen-Ji Dong; Peter Timmins; Herbert C Cheung; Paul R Rosevear; Jill Trewhella
Journal:  Biochemistry       Date:  2003-07-01       Impact factor: 3.162

4.  Recapitulation and design of protein binding peptide structures and sequences.

Authors:  Vanita D Sood; David Baker
Journal:  J Mol Biol       Date:  2006-01-31       Impact factor: 5.469

Review 5.  The unique functions of cardiac troponin I in the control of cardiac muscle contraction and relaxation.

Authors:  R John Solaro; Paul Rosevear; Tomoyoshi Kobayashi
Journal:  Biochem Biophys Res Commun       Date:  2007-12-26       Impact factor: 3.575

6.  Phosphorylation-induced distance change in a cardiac muscle troponin I mutant.

Authors:  W J Dong; M Chandra; J Xing; M She; R J Solaro; H C Cheung
Journal:  Biochemistry       Date:  1997-06-03       Impact factor: 3.162

7.  Phosphorylation or glutamic acid substitution at protein kinase C sites on cardiac troponin I differentially depress myofilament tension and shortening velocity.

Authors:  Eileen M Burkart; Marius P Sumandea; Tomoyoshi Kobayashi; Mahta Nili; Anne F Martin; Earl Homsher; R John Solaro
Journal:  J Biol Chem       Date:  2003-01-27       Impact factor: 5.157

8.  Protein kinase A-mediated phosphorylation of cMyBP-C increases proximity of myosin heads to actin in resting myocardium.

Authors:  Brett A Colson; Tanya Bekyarova; Matthew R Locher; Daniel P Fitzsimons; Thomas C Irving; Richard L Moss
Journal:  Circ Res       Date:  2008-07-03       Impact factor: 17.367

9.  Structural and functional consequences of the cardiac troponin C L48Q Ca(2+)-sensitizing mutation.

Authors:  Dan Wang; Ian M Robertson; Monica X Li; Michelle E McCully; Melissa L Crane; Zhaoxiong Luo; An-Yue Tu; Valerie Daggett; Brian D Sykes; Michael Regnier
Journal:  Biochemistry       Date:  2012-05-23       Impact factor: 3.162

10.  PKA phosphorylation of cardiac troponin I modulates activation and relaxation kinetics of ventricular myofibrils.

Authors:  Vijay Rao; Yuanhua Cheng; Steffen Lindert; Dan Wang; Lucas Oxenford; Andrew D McCulloch; J Andrew McCammon; Michael Regnier
Journal:  Biophys J       Date:  2014-09-02       Impact factor: 4.033

View more
  28 in total

1.  Cardiac Myosin-binding Protein C and Troponin-I Phosphorylation Independently Modulate Myofilament Length-dependent Activation.

Authors:  Mohit Kumar; Suresh Govindan; Mengjie Zhang; Ramzi J Khairallah; Jody L Martin; Sakthivel Sadayappan; Pieter P de Tombe
Journal:  J Biol Chem       Date:  2015-10-09       Impact factor: 5.157

Review 2.  Moving beyond simple answers to complex disorders in sarcomeric cardiomyopathies: the role of integrated systems.

Authors:  Andrea E Deranek; Matthew M Klass; Jil C Tardiff
Journal:  Pflugers Arch       Date:  2019-03-08       Impact factor: 3.657

3.  Mechanism of Cardiac Troponin C Calcium Sensitivity Modulation by Small Molecules Illuminated by Umbrella Sampling Simulations.

Authors:  Jacob D Bowman; William H Coldren; Steffen Lindert
Journal:  J Chem Inf Model       Date:  2019-05-29       Impact factor: 4.956

4.  Restrictive Cardiomyopathy Troponin I R145W Mutation Does Not Perturb Myofilament Length-dependent Activation in Human Cardiac Sarcomeres.

Authors:  Alexey V Dvornikov; Nikolai Smolin; Mengjie Zhang; Jody L Martin; Seth L Robia; Pieter P de Tombe
Journal:  J Biol Chem       Date:  2016-08-24       Impact factor: 5.157

5.  Atomic resolution probe for allostery in the regulatory thin filament.

Authors:  Michael R Williams; Sarah J Lehman; Jil C Tardiff; Steven D Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-08       Impact factor: 11.205

6.  Molecular Dynamics and Umbrella Sampling Simulations Elucidate Differences in Troponin C Isoform and Mutant Hydrophobic Patch Exposure.

Authors:  Jacob D Bowman; Steffen Lindert
Journal:  J Phys Chem B       Date:  2018-08-02       Impact factor: 2.991

7.  Multi-scale Modeling of the Cardiovascular System: Disease Development, Progression, and Clinical Intervention.

Authors:  Yanhang Zhang; Victor H Barocas; Scott A Berceli; Colleen E Clancy; David M Eckmann; Marc Garbey; Ghassan S Kassab; Donna R Lochner; Andrew D McCulloch; Roger Tran-Son-Tay; Natalia A Trayanova
Journal:  Ann Biomed Eng       Date:  2016-05-02       Impact factor: 3.934

Review 8.  The continuing evolution of cardiac troponin I biomarker analysis: from protein to proteoform.

Authors:  Daniel Soetkamp; Koen Raedschelders; Mitra Mastali; Kimia Sobhani; C Noel Bairey Merz; Jennifer Van Eyk
Journal:  Expert Rev Proteomics       Date:  2017-10-16       Impact factor: 3.940

9.  Molecular Modeling of the Structural and Dynamical Changes in Calcium Channel TRPV5 Induced by the African-Specific A563T Variation.

Authors:  Lingyun Wang; Ross P Holmes; Ji-Bin Peng
Journal:  Biochemistry       Date:  2016-02-15       Impact factor: 3.162

Review 10.  Cardiac troponin structure-function and the influence of hypertrophic cardiomyopathy associated mutations on modulation of contractility.

Authors:  Yuanhua Cheng; Michael Regnier
Journal:  Arch Biochem Biophys       Date:  2016-02-04       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.